中药材GAP
Search documents
产新季来临价格承压 中药材市场深度调整
Zheng Quan Ri Bao Zhi Sheng· 2025-10-14 15:40
本报记者 殷高峰 "10月份是秋季产新高峰季,当归、黄芪、党参等大宗品种新货集中上市,市场供应量显著增加。"刘红 卫表示,据主要产区反馈,甘肃渭源县作为"中国党参之乡",今年已完成党参、当归、黄芪等中药材种 植35万亩,国庆节后已大规模采挖。 而从采购端来看,集采背景下,中成药企业严格控制原料成本,采购策略趋于保守。 目前,第二轮全国中药饮片联盟集采已经启动。在刘红卫看来,此次集采覆盖面更广、品种更多,将进 一步促使企业通过规模化、标准化降本增效,这预示着中药行业将迎来新一轮价格调整。 "中药材价格底部态势或将延续至2025年底,甚至可能延续到2026年。尤其随着今年下半年根茎类药材 全面产新,产能释放进入高峰期,低价品种数量或将进一步增加。"刘红卫说。 行业变革或提速 进入10月份,中药材市场迎来全年产销的关键时期,在供需矛盾加剧、政策引导加强等因素的影响下, 行业面临持续调整。 "一方面,秋季产新(中药材产新主要指中药材产区在特定季节集中产出新鲜药材)集中推进,市场供 应量短期激增;另一方面,国家层面推动中医药高质量发展的政策框架逐步落地,引导产业向规范化、 标准化方向转型。"中康云瓴中药产业大数据中心智 ...
重庆市药品监督管理局关于中药材GAP符合性信息的通告
Zhong Guo Zhi Liang Xin Wen Wang· 2025-09-03 07:41
Group 1 - The announcement by the National Medical Products Administration and other authorities regarding the compliance of traditional Chinese medicine (TCM) material production quality management standards is highlighted [2] - Taiji Group Chongqing Fuling Pharmaceutical Factory and Chongqing Traditional Chinese Medicine Slice Factory have conducted audits on their supplier, Zhalantun Tianli Agricultural and Sideline Products Purchase and Sale Co., Ltd., and found it compliant with GAP requirements [2] - A comprehensive evaluation of the TCM materials used by Taiji Group and Chongqing Traditional Chinese Medicine Slice Factory confirmed compliance with the "Traditional Chinese Medicine Material Production Quality Management Standards" [2] Group 2 - The compliance information table indicates that Taiji Group Chongqing Fuling Pharmaceutical Factory produces "Huo Xiang Zheng Qi Oral Liquid" and uses Zhalantun Tianli as a supplier for "Cang Zhu" material [3] - The planting base for "Cang Zhu" is located in Inner Mongolia, with an area of 5060 mu [3] - Chongqing Traditional Chinese Medicine Slice Factory is also involved in the production of "Cang Zhu" slices, confirming the compliance of their material sourcing [3]
“千年药乡”药材有了“数字身份证”
Ke Ji Ri Bao· 2025-06-11 08:18
Group 1 - The core viewpoint emphasizes the transformation of traditional Chinese medicine (TCM) through technology and the establishment of a comprehensive industrial chain in the medicinal herb sector in Weiyuan, Gansu Province [1][2][4] - Gansu Baishitang Organic Traditional Chinese Medicine Co., Ltd. utilizes a "dragon head enterprise + cooperative + processing workshop + base + farmers" model for full digital management from planting to harvesting [2][3] - The "six unifications traceable" management model has been implemented, ensuring standardized production and traceability of medicinal herbs, enhancing the quality and safety of TCM products [2][4] Group 2 - Weiyuan County plans to establish 68,000 acres of GAP bases by 2024, accounting for 29.4% of the total in Gansu Province, with a target of 133,000 acres by 2025 [2] - The county has invested 340 million yuan in a provincial economic development zone, attracting 76 deep processing enterprises and processing over 8,000 tons of fresh medicinal materials annually [4] - The geographical indication brand value of "Weiyuan White Strip Ginseng" has reached 1.976 billion yuan, with 24 enterprises using this brand to develop a diverse range of products [4]